Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v4-EN
Language English English
Date Updated 2020-07-02 2020-07-02
Drug Identification Number 02409097 02409097
Brand name GD-TRANEXAMIC ACID GD-TRANEXAMIC ACID
Common or Proper name GD-TRANEXAMIC ACID GD-TRANEXAMIC ACID
Company Name GENMED A DIVISION OF PFIZER CANADA ULC GENMED A DIVISION OF PFIZER CANADA ULC
Ingredients TRANEXAMIC ACID TRANEXAMIC ACID
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code B02AA B02AA
ATC description ANTIFIBRINOLYTICS ANTIFIBRINOLYTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-06-30
Actual start date 2020-06-30
Estimated end date 2020-08-07 2020-08-07
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments